PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm CEO steps down & Appointment of MD, page-175

  1. 4,343 Posts.
    lightbulb Created with Sketch. 6886
    Yeah its a tough one...on the one hand we have a brilliant product, irrefutable data, a real winning proposition...the brightest prospects I have come across to date hands down my opinions and not advice. Science? Incredible.

    But yes, these hiccups need to be addressed and we need management certainty going forward.

    In my humble, PR has done a great job going from Micro to Small cap...we now step up, specially next year and onwards, it is a VERY different strategy that needs to be employed. In the interim I can handle Paul doing what he does, but he will undoubtedly need help going forward, we definitely need an independent and separated chair as soon as practically possible or Paul takes chair and we get a new CEO. I wait patiently to see what is said in the upcoming AGM.

    We are owners of the company, we must also assist them (constructively) to assist us, specially if we are long term owners.



    Last edited by Mozzarc: 24/11/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.